Bristol-Myers Granted Right to Buy Promedior

Bristol-Myers Squibb said that it has been granted the exclusive right to buy privately held Promedior and its experimental fibrosis treatment for up to $1.25 billion.

from WSJ.com: US Business http://ift.tt/1KA4d68
via IFTTT